Recurrence of Helicobacter pylori Infection after Successful Eradication Therapy in Egyptian Patients

Faculty Medicine Year: 2020
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Acta scientific gastrointestinal disorders Acta scientific international open library Volume:
Keywords : Recurrence , Helicobacter pylori Infection after Successful    
Abstract:
Background: Helicobacter pylori (H. pylori), a highly prevalent gastrointestinal organism, infects more than 50% of the global population. It is the most common risk factor for peptic ulcer disease, cancer stomach and gastric lymphoma. Eradication therapy regimens for H. pylori are highly effective. However, bacterial resistance to antibiotics and patients non￾adherence to the treatment regimens significantly increased the recurrence rates of H. pylori infection in the last few decades. Patients and Methods: We evaluated and followed up 157 patients for one year after confirmed successful eradication of H. pylori infection. We investigated the patients at 3, 6, 9 and 12 months for recurrence of H. pylori infection using urea breath and stool antigen tests. Study Aim: To assess the prevalence and possible risk factors of H. pylori recurrence in Egyptian patients after eradication therapy. Results and Conclusion: We found a one-year recurrence rate of 19% after successful eradication therapy of H. pylori. The education level of the patients and alcohol consumption were the most significant predictors of H. pylori recurrence. The one-year recurrence rate in our study is high but comparable to those reported in the developing countries most probably due to high rates of re-infection and non-adherence to the preventive measures
   
     
 
       

Author Related Publications

  • Mohammed Ahmed Ali Bassiouni, "Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients", Wolters Kluwer Health, Inc., 2017 More
  • Mohammed Ahmed Ali Bassiouni, "Lipocalin-2: A novel diagnostic marker for hepatocellular carcinoma", IOS press, 2020 More
  • Mohammed Ahmed Ali Bassiouni, "Management of HCV‑related decompensated cirrhosis with direct‑acting antiviral agents: who should be treated?", Springer, 2019 More
  • Mohammed Ahmed Ali Bassiouni, "Prevalence and Risk Factors of Minimal Hepatic Encephalopathy in Patients with Compensated Liver Cirrhosis", Ain Shams University, 2020 More
  • Mohammed Ahmed Ali Bassiouni, "Clinical Outcomes of Upper Gastrointestinal Bleeding in Egyptian Patients with Decompensated Liver Cirrhosis, Does the Bleeding Source Matter?", Ain Shams University, 2020 More

Department Related Publications

  • Ehab Mohamed Ahmed Salm, "دور الانترولوكين 1 بيتا في امراض المعدة والاثني عشر المصاحبة للبكتريا الحلزونية البوابية", لايوجد, 1900 More
  • Hamed Abdelaziz Deraz, "مدى انتشار الالتهاب الكبدى الفيروس ب ، س فى الشرقية ", لايوجد, 1900 More
  • Helmy Mohamed Youssef Elgendy, "تقييم طريقة الباكتك 960: ذو النظام الى مقارنة مع الطريقة التكبير " المبزالجينى والوسط الصلب لنمو وتحديد بكتريا الدرن من العينات الخاصة بمرض الدرن", لايوجد, 1900 More
  • Helmy Mohamed Youssef Elgendy, "مقارنة وسيلة استخدام العينات المأخوذة بالابر الرقيقة بواسطة الموجات الصوتية مع الوسائل للاخرى فى تشخيص اورام الكبد", لايوجد, 1900 More
  • Helmy Mohamed Youssef Elgendy, "تحديد الاصابة بميكروب الكامبيليوباكتر فى 200 مريضا مصابا بعسر الهضم بطريقة أخذ عينات من المعدة واختبارها بطريقة اليورياز", لايوجد, 1900 More
Tweet